The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Sickle cell disease related mortality in the United States (1999-2009)
Abstract
BACKGROUND: Little is known about the national outcome of children and adults with sickle cell disease (SCD) given contemporary care. PROCEDURE: We investigated the number of deaths, standardized crude and age-adjusted mortality rates, and causes of death among individuals with SCD across the United States during 1999-2009 according to death certificates by using a publicly available website (http://wonder.cdc.gov/). Data were compared to mortality during 1979-1998. RESULTS: When compared to 1979-1998, mortality significantly decreased by 61% in infants <1 year of age, by 67% in children aged 1-4 years, and by 22-35% in children aged 5-19 years. After 19 years of age, mortality rates increased from 0.6 in the 15-19 year group to 1.4/100,000 in the 20-24 year group, corresponding to the transition period from pediatric to adult medical care, and this increase was similar during 1979-1998. Although the age groups with the highest mortality were 35-44 years for males and 45-54 years for females, there was a tendency for longer survival because there were more deaths among those individuals 55-74 years of age compared to previous years. For all individuals, the causes of deaths were cardiac disease (31.6%), respiratory (28.1%), renal (16.4%), infectious (14.4%), neurologic (11.9%), and gastrointestinal and hepatobiliary (9.2%) in nature. Cancer was the cause of death in <1%. CONCLUSION: Mortality during childhood has decreased significantly. However, the transition period from pediatric to adult care is critical. Risk-reduction, monitoring, and early treatment intervention of cardiovascular disease in adults is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 4×
“In 1994, the National Institutes of Health-sponsored multi-center Cooperative Study of Sickle Cell Disease (CSSCD) estimated that the median survival for individuals with Hb SS was 42 years for males and 48 years for female patients followed at the participating sickle cell centers [2].”
BackgroundResultInfluentialAdams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422502 · Cited by 1,234
Population Estimates of Sickle Cell Disease in the U.S.
Hassell, K. L. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2009.12.022 · Cited by 1,211
Prophylaxis with Oral Penicillin in Children with Sickle Cell Anemia
Gaston, M. H., Verter, J. I., Woods, G., Pegelow, C., Kelleher, J., Presbury, G., Zarkowsky, H., Vichinsky, E., Iyer, R., Lobel, J. S., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142501 · Cited by 1,162
Improved survival of children and adolescents with sickle cell disease
Quinn, C. T., Rogers, Z. R., McCavit, T. L., & Buchanan, G. R. (2010) · Blood · doi:10.1182/blood-2009-07-233700 · Cited by 907
Wang, W. C., Ware, R. E., Miller, S. T., Iyer, R. V., Casella, J. F., Minniti, C. P., Rana, S., Thornburg, C. D., Rogers, Z. R., Kalpatthi, R. V., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60355-3 · Cited by 803
Deaths: preliminary data for 2002.
Kochanek, K. D., & Smith, B. L. (2004) · PubMed · Cited by 700
Gill, F., Sleeper, L., Weiner, S., Brown, A., Bellevue, R., Grover, R., Pegelow, C., & Vichinsky, E. (1995) · Blood · doi:10.1182/blood.v86.2.776.bloodjournal862776 · Cited by 518
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up
Steinberg, M. H., McCarthy, W. F., Castro, O., Ballas, S. K., Armstrong, F. D., Smith, W., Ataga, K., Swerdlow, P., Kutlar, A., DeCastro, L., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21699 · Cited by 486
Sickle cell pain: a critical reappraisal
Ballas, S. K., Gupta, K., & Adams-Graves, P. (2012) · Blood · doi:10.1182/blood-2012-04-383430 · Cited by 445
Committee on Infectious Diseases (2000) · Pediatrics · doi:10.1542/peds.106.2.362 · Cited by 390
Survival of children with sickle cell disease
Quinn, C. T., Rogers, Z. R., & Buchanan, G. R. (2004) · Blood · doi:10.1182/blood-2003-11-3758 · Cited by 377
Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results
Lee, M. T., Piomelli, S., Granger, S., Miller, S. T., Harkness, S., Brambilla, D. J., Adams, R. J., & for the STOP Study Investigators (2006) · Blood · doi:10.1182/blood-2005-10-009506 · Cited by 319
Newborn Screening for Sickle Cell Disease: Effect on Mortality
Vichinsky, E., Hurst, D., Earles, A., Kleman, K., & Lubin, B. (1988) · Pediatrics · doi:10.1542/peds.81.6.749 · Cited by 304
Newborn Screening for Sickle Cell Disease: Effect on Mortality
Vichinsky, E., Hurst, D., Earles, A., Kleman, K., & Lubin, B. (1989) · Pediatrics · doi:10.1542/peds.83.5.834 · Cited by 303
Causes of death in sickle-cell disease in Jamaica.
Thomas, A. N., Pattison, C., & Serjeant, G. R. (1982) · BMJ · doi:10.1136/bmj.285.6342.633 · Cited by 266
Halasa, N. B., Shankar, S. M., Talbot, T. R., Arbogast, P. G., Mitchel, E. F., Wang, W. C., Schaffner, W., Craig, A. S., & Griffin, M. R. (2007) · Clinical Infectious Diseases · doi:10.1086/516781 · Cited by 253
Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease
Fitzhugh, C. D., Lauder, N., Jonassaint, J. C., Telen, M. J., Zhao, X., Wright, E. C., Gilliam, F. R., & De Castro, L. M. (2010) · American Journal of Hematology · doi:10.1002/ajh.21569 · Cited by 224
Health Supervision for Children with Sickle Cell Disease
Section on Hematology/Oncology and Committee on Genetics (2002) · Pediatrics · doi:10.1542/peds.109.3.526 · Cited by 193
Adamkiewicz, T. V., Silk, B. J., Howgate, J., Baughman, W., Strayhorn, G., Sullivan, K., & Farley, M. M. (2008) · Pediatrics · doi:10.1542/peds.2007-0018 · Cited by 170
Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease
Mekontso Dessap, A., Leon, R., Habibi, A., Nzouakou, R., Roudot-Thoraval, F., Adnot, S., Godeau, B., Galacteros, F., Brun-Buisson, C., Brochard, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1606oc · Cited by 170
Pass, K. A., Lane, P. A., Fernhoff, P. M., Hinton, C. F., Panny, S. R., Parks, J. S., Pelias, M. Z., Rhead, W. J., Ross, S. I., Wethers, D. L., et al. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.109437 · Cited by 158
Adamkiewicz, T. V., Sarnaik, S. A., Buchanan, G. R., Iyer, R. V., Miller, S. T., Pegelow, C. H., Rogers, Z. R., Vichinsky, E. P., Elliott, J. A., Facklam, R. R., et al. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00331-7 · Cited by 147
Alvarez, O. A., Miller, S. T., Wang, W. C., Luo, Z., McCarville, M. B., Schwartz, G. J., Thompson, B., Howard, T. H., Iyer, R. V., RANA, S. R., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24100 · Cited by 131
Self-citationMachado, R. F., Mack, A. K., Martyr, S. E., Barnett, C. F., MacArthur, P. H., Sachdev, V., Ernst, I., Hunter, L. A., Coles, W. A., Nichols, J., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06417.x · Cited by 122
Myocardial ischaemia in children with sickle cell disease
de Montalembert, M. (2004) · Archives of Disease in Childhood · doi:10.1136/adc.2003.027326 · Cited by 65
Gordeuk, V. R., Campbell, A., RANA, S. R., Nouraie, M. S., Niu, X., Minniti, C. P., Sable, C., Darbari, D. S., Dham, N., Onyekwere, O. C., et al. (2009) · Blood · doi:10.1182/blood-2009-04-218040 · Cited by 61
Talbot, T. R., Poehling, K. A., Hartert, T. V., Arbogast, P. G., Halasa, N., Mitchel, E. F., Schaffner, W., Craig, A. S., Edwards, K. M., & Griffin, M. R. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000133046.60555.de · Cited by 48
Frempong, T. A., & Pearson, H. A. (2007) · PubMed · Cited by 37
Hydroxyurea Therapy Reduces Mortality Among Children with Sickle Cell Disease
Lobo, C. L. D. C., Hankins, J. S., de Moura, P. G., & Pinto, J. F. D. C. (2010) · Blood · doi:10.1182/blood.v116.21.843.843 · Cited by 11
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Ware, R. E., de Montalembert, M., Tshilolo, L., & Abboud, M. R. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30193-9 · Cited by 977
Kavanagh, P. L., Fasipe, T. A., & Wun, T. (2022) · JAMA · doi:10.1001/jama.2022.10233 · Cited by 478
Sickle cell disease: renal manifestations and mechanisms
Nath, K. A., & Hebbel, R. P. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.8 · Cited by 369
Lubeck, D., Agodoa, I., Bhakta, N., Danese, M., Pappu, K., Howard, R., Gleeson, M., Halperin, M., & Lanzkron, S. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.15374 · Cited by 336
Metadata
- Authors
- Hamideh, D., & Alvarez, O.
- Venue
- Pediatric Blood & Cancer
- Publisher
- Wiley
- Published
- 2013-04-23
- Volume
- 60
- Issue
- 9
- Pages
- 1482-1486
- ISSN
- 1545-5009 (ISSN-L)
- OpenAlex
- W2152076865
- Cited by
- 290
- References
- 34
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.